J Neurol Surg A Cent Eur Neurosurg 2024; 85(02): 215-220
DOI: 10.1055/s-0043-1776264
Case Report

Long-Term Survival after Primary Ewing's Sarcoma of the Skull with Intracranial Extension

Nikolai G. Rainov
1   MVZ Wirbelsäulenzentrum München-Taufkirchen, München, Germany
2   Department of Neurosurgery, University Hospital Heart and Brain, Pleven, Bulgaria
,
Dimitar Haritonov
2   Department of Neurosurgery, University Hospital Heart and Brain, Pleven, Bulgaria
,
Volkmar Heidecke
3   Department of Neurosurgery, Universitätsklinikum Augsburg, Augsburg, Germany
› Author Affiliations

Abstract

Background and Objective Primary Ewing's sarcoma of the skull is a very rare malignant neoplasm, predominantly occurring in children and adolescents. We describe here the clinical, neuroradiologic, and histopathologic features of a patient with primary Ewing's sarcoma of the skull and discuss the standards of therapy for this type of tumor.

Clinical Presentation This 18-year-old male patient presented with a primary Ewing's sarcoma of the skull, involving the dura of the frontal and parietal lobes of the left cerebral hemisphere. He was treated with gross total surgical excision of tumor, skull reconstruction, chemotherapy, and irradiation. Twelve years after the surgery, the patient has no evidence of local recurrence or distant metastases. Radical surgical excision of the primary tumor with safety margins is thought to play a role in the favorable clinical course.

Conclusion The presented case is the longest surviving patient after treatment of primary Ewing's sarcoma of the skull bone. This rare type of tumor may allow better survival rates under adequate management than sarcoma elsewhere in the body.



Publication History

Received: 22 September 2019

Accepted: 13 February 2020

Article published online:
08 November 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Martin E, Senders JT, Ter Wengel PV, Smith TR, Broekman MLD. Treatment and survival of osteosarcoma and Ewing sarcoma of the skull: a SEER database analysis. Acta Neurochir (Wien) 2019; 161 (02) 317-325
  • 2 Martin E, Radomski S, Harley EH. Pediatric Ewing sarcoma of the head and neck: A retrospective survival analysis. Int J Pediatr Otorhinolaryngol 2019; 117: 138-142
  • 3 Bhattacharjee S, Venkata SR, Uppin MS. Skull and spinal Ewing's sarcoma in children: an institutional study. J Pediatr Neurosci 2018; 13 (04) 392-397
  • 4 Bouaoud J, Temam S, Cozic N. et al. Ewing's Sarcoma of the head and neck: margins are not just for surgeons. Cancer Med 2018; 7 (12) 5879-5888
  • 5 Hadfield MG, Quezado MM, Williams RL, Luo VY. Ewing's family of tumors involving structures related to the central nervous system: a review. Pediatr Dev Pathol 2000; 3 (03) 203-210
  • 6 Yang MJ, Whelan R, Madden J. et al. Intracranial Ewing sarcoma: four pediatric examples. Childs Nerv Syst 2018; 34 (03) 441-448
  • 7 Moschovi M, Alexiou GA, Tourkantoni N. et al. Cranial Ewing's sarcoma in children. Neurol Sci 2011; 32 (04) 691-694
  • 8 Desai KI, Nadkarni TD, Goel A, Muzumdar DP, Naresh KN, Nair CN. Primary Ewing's sarcoma of the cranium. Neurosurgery 2000; 46 (01) 62-68 , discussion 68–69
  • 9 Choi SW, Ko H. Primary Ewing sarcoma of the squamous temporal bone with intracranial and extracranial extension: a rare cause of sudden sensorineural hearing loss. Head Neck 2019; 41 (03) E38-E41
  • 10 Woo CG, Lee B, Song JS, Cho KJ. Clinicopathologic features of the non-CNS primary Ewing sarcoma family of tumors in the head and neck region. Appl Immunohistochem Mol Morphol 2018; 26 (09) 632-639
  • 11 Salunke PS, Gupta K, Malik V. et al. Primary Ewing's sarcoma of cranial bones: analysis of ten patients. Acta Neurochir (Wien) 2011; 153 (07) 1477-1485
  • 12 Erol FS, Ozveren MF, Ozercan IH, Topsakal C, Akdemir I. Primary Ewing's sarcoma of the occipital bone: case report. Neurol Med Chir (Tokyo) 2001; 41 (04) 206-209
  • 13 Bhatoe HS, Deshpande GU. Primary cranial Ewing's sarcoma. Br J Neurosurg 1998; 12 (02) 165-169
  • 14 Watanabe H, Tsubokawa T, Katayama Y, Koyama S, Nakamura S. Primary Ewing's sarcoma of the temporal bone. Surg Neurol 1992; 37 (01) 54-58
  • 15 Krishnamani K, Kumar TN, Gandhi LV, Raghunadharao D, Sadashivudu G, Megha U. Primary Ewing's sarcoma of the cranium: case series and review of literature. J Cancer Res Ther 2014; 10 (02) 377-380
  • 16 Berger M, Fagioli F, Abate M. et al. Unusual sites of Ewing sarcoma (ES): a retrospective multicenter 30-year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) and Italian Sarcoma Group (ISG). Eur J Cancer 2013; 49 (17) 3658-3665
  • 17 Kawano H, Nitta N, Ishida M, Fukami T, Nozaki K. Primary pericranial Ewing's sarcoma on the temporal bone: a case report. Surg Neurol Int 2016; 7 (Suppl. 15) S444-S448
  • 18 Castle M, Rivero M, Marquez J. Primary Ewing's sarcoma of the skull: radical resection and immediate cranioplasty after chemotherapy. A technical note. Childs Nerv Syst 2013; 29 (02) 303-306
  • 19 Carlotti Jr CG, Drake JM, Hladky JP, Teshima I, Becker LE, Rutka JT. Primary Ewing's sarcoma of the skull in children. Utility of molecular diagnostics, surgery and adjuvant therapies. Pediatr Neurosurg 1999; 31 (06) 307-315
  • 20 Grier HE, Krailo MD, Tarbell NJ. et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348 (08) 694-701